Member Info for dactions

I see Malcy in his blog has added some encouragement.
https://www.malcysblog.com/2023/01/oil-price-coro-and-finally/
He sums up the recent Philippine's RNS with:
" As Coro continues its renewables journey in South East Asia this announcement is pretty much self explanatory. This partner restructuring is preparing the way for these larger 100MW projects in the Philippines in order to get ready for FID/RTB.

I have recently, like most, been hearing that management at Coro has become a bit more active and Twitter has been all over Balochistan and further SE Asia deals in particular. Should this be the case there is every chance that Coro might be about to come back onto the radar screen.

If that is the case then the shares at 0.225p, having halved since the year’s peak may well be worth, as they used to say, a turn of the head."

OK Karl - if you're starting out investing, really good luck to you & all the best.

Yes - like your posting history ;-) 1

"I have a good feeling there's good news ahead "
It'd be great if you could flesh out that good feeling with some facts please ?!?

I've been disappointed by James Parson's management of Coro particularly since I originally came in prior to the renaming of the Co and the run down of the Italian portfolio. All these years later it is now earning money with them. Now with the efforts concentrated on the far-east I was impressed with the way the Vietnam project is turning into a plus asset.

Today, we see the changes happening in the Philippines and there has been persistent talk regarding ****stan.

With the sp where it is - surely this could be a turning point worth considering ?

I saw today’s RNS suspending the shares pending an announcement. I am assuming the Science Group will acquire the shares at the low price of slightly above 2p. Many of us recognised the sp was only going one way after the heated discussions around 6p and in my case wrote that I was selling out in the market at 5.5p rather than wait any longer.

I incurred losses having held from the Corac days but even I didn’t see that the Science Group would “massage” the news output so incredibly well that even the long term Institutional shareholders would accept the current low sp.

I’m sorry for my fellow LTHs who have incurred an even worse financial outcome than me. What I take from this though is that the Science Group are an organisation to watch for the future - clever and a share to watch.

Today's RNS - what a tease ?!?

But still it's one step closer - Good luck all LTHs

DarthInvestor - I think you'll find the FDA trial was 6 months duration wasn't it ? Or is that me just losing all sense of time given how long the pot at FUM has been slowing coming to boil ;-)

I agree Scharnhost about broker change. Wouldn’t normally rate as a shareprice positive but this confirms MHC is alive and kicking and will at least underpin the sp while we await confirmation that the company still has a good financial base. Something, despite the lack of news, I do believe will still be the case. A little more patience needed whilst we await confirmation.

Yes BOBO8989 - news that we get the permission for the initial afforestation project would be the kind of news that will lift the sp. On the subject of the current rate for Lumber futures, I don't buy that this is the problem affecting the sp. Sure, if Lumber futures go down, just like it swinging up again, will affect the sp - but, in my opinion, only marginally. The distressed selling of Rhino Ventures over a prolonged period was, in my opinion, what took the sp so low. After that, not unnaturally, other investors think there must be something wrong with the Company. The provisional figures for the year just past, prove quite clearly that they have done really well. Remember they did this despite the Covid pandemic, war in Europe where their market is historically strong. As a lth, I feel the trading outlook is excellent but patience is needed still with the sp.

Let's hope the afforestation project gets started soon.

Good points jamrock - given the size of your holding, have you emailed the Company to ask why we have had no update ?
Considering that Penny clearly alluded to wishing to update the market in the 4th quarter that has just passed.

I added Wednesday at 1.725 ahead of the announcement of 2022's trading figures. In a better market, I should be quids in for anticipating correctly that the figures would be good - but the sp is still down. You have to ask what does the market expect from Woodbois ? The prolonged distressed selling by Rhino Ventures must be the catalyst here - they're now down to 9% whereas they were nudging 29% I recall. Fortunately, Lombard Odier, which is now the largest declared holder at 14% is holding steady and has been a short-term funder of WBI.

Woodbois is still waiting for final approval of an afforestation project, which when approval is announced maybe the nudge we need to get the sp on the up again. Short of a political calamity in Gabon, I think the outlook is distinctly good for Woodbois and I'm confident we'll see really good growth this year in the shareprice.

Patience is the name of the game right now for us long-term holders. GLA

Irrespective of who is selling the LFT tests on Amazon, please can someone enlighten me what is MHC's link with FlowFlex ? Do we now any specific figures relating to MHC's business with FlowFlex to help us judge how MHC is doing ?

Bottom_feeder
Thanks for website find for Eroxon. I see the site says expected availability 15th January to 15th February. The Belgian website is managed by Shop-Apotheke BV, a small company with limited liability under Dutch law with a registered capital of €18,000 but small or large, this is the first time we've seen anything specific by way of sales info. As for pricing Euros 29.50 for 4 tubes - I recall seeing/hearing in the past comment from the FUM (Proactive discussion ?) that would sell for approx £5. I guess Eroxon would not be zero vat rated, so Euros 29.50 inc. vat and E/£ exchange rate is similar.

Gosh, after all these years of waiting, it is so good to see some tangible info - good luck all.

shal1000 - I guess you're looking for 3p if we're both talking about Woodbois. I'm looking for higher having subscribed at their 6p placing a while back although I've lowered my average a bit since. We'll have 2022 trading news soon if they follow to past form - would hope by next week at latest

PetitStVincent - I've liked all your consistently thoughtful analyses these past years. I am not surprised though that Coopers haven't yet promoted the product, having seemingly wasted 1 year of their 5 years contract. It's been clear to me that the BOD decided long ago to wait for FDA clearance. Remember, there is supposedly little in the way of active ingredients in DermaSys - or so I read somewhere in journals . I don't know what the latest on patent expiry is but the product at this base level of just DermaSys must be open to easier copycatting wouldn't you think ?

So, better to grab all the major markets at the outset to establish and maximise Eroxon's potential. I just hope Futura has got itself ready for the day the FDA decision lands.

Well done ace2326 - totally agree with you.

I tend to be more verbose & analytical in my posts on MHC, but at heart you are saying exactly what I am thinking.

Thanks ace2326

shal1000 - that's not been my experience over the years with WBI. I think it's a direct correlation of the really persistent selling by Rhino Ventures of their large holding - which at the various prices obtained looks like 'distressed selling' ? Perhaps related to the bitcoin meltdown as some posters suggested at the time.

There was a large SELL this morning:
09:09:28 1.62 3,237,830 clearly under the spread at the time 1.70-1.75p
But there was a later BUY:
12:15:05 1.746 1,350,000

I think this has been overdone and, as we are due provisional trading figures for 2022 soon, I'm confident we'll see a welcome return to growth in the share price. GLA

Does anyone else wonder if the amazing ramp we saw earlier last year was orchestrated by associates in some nebulous way to aid the massive selling down of Rhino Ventures holdings ?

Thanks smudge99 - I mistakenly quoted Genome Store in my post whereas you correctly stated it's Nell Health.

The company was acquired 6/2021 for £1,152,000 in shares plus £50,000 in cash and deferred consideration of £1m which we subsequently learned was not paid as they didn't meet performance criteria. I think the shares were originally allocated at 3.5p and we've seen a drip drip drop in the sp since then. So it's likely they would have been a seller of MHC shares since.